125 related articles for article (PubMed ID: 31966894)
1. The expression of ERβ2, Bcl-xl and Bax in non-small cell lung cancer and associated with prognosis.
Liu J; Nie Z; Lei Y; Yang S; Liu Z
Int J Clin Exp Pathol; 2017; 10(9):10040-10046. PubMed ID: 31966894
[TBL] [Abstract][Full Text] [Related]
2. The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression.
Liu ZG; Lei YY; Li WW; Chen ZG
Med Oncol; 2013; 30(3):592. PubMed ID: 23677568
[TBL] [Abstract][Full Text] [Related]
3. The expression of estrogen receptors β2, 5 identifies and is associated with prognosis in non-small cell lung cancer.
Liu Z; Liao Y; Tang H; Chen G
Endocrine; 2013 Oct; 44(2):517-24. PubMed ID: 23475473
[TBL] [Abstract][Full Text] [Related]
4. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
[TBL] [Abstract][Full Text] [Related]
6. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers.
Groeger AM; Esposito V; De Luca A; Cassandro R; Tonini G; Ambrogi V; Baldi F; Goldfarb R; Mineo TC; Baldi A; Wolner E
Histopathology; 2004 Jan; 44(1):54-63. PubMed ID: 14717670
[TBL] [Abstract][Full Text] [Related]
8. Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Kanczuga-Koda L; Witkowska E; Sulkowski S
Ann N Y Acad Sci; 2007 Jan; 1095():53-61. PubMed ID: 17404017
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptorβ2 regulates interlukin-12 receptorβ2 expression via p38 mitogen-activated protein kinase signaling and inhibits non-small-cell lung cancer proliferation and invasion.
Liu ZG; Jiao XY; Chen ZG; Feng K; Luo HH
Mol Med Rep; 2015 Jul; 12(1):248-54. PubMed ID: 25695486
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine.
Krug LM; Miller VA; Filippa DA; Venkatraman E; Ng KK; Kris MG
Lung Cancer; 2003 Feb; 39(2):139-43. PubMed ID: 12581565
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis.
Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
13. [Expression and Significance of bag-1, bcl-2 in Non-small Cell Lung Cancer and the Correlation with Multi-drug Resistance.].
Ma J; Zhu W; Zhou Q
Zhongguo Fei Ai Za Zhi; 2009 Oct; 12(10):1089-94. PubMed ID: 20723348
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma].
Lee DS; Kang SB; Baek JT; Nam SW; Lee KM; Ahn BM; Lee EH; Han SW; Chung IS
Korean J Gastroenterol; 2005 Jun; 45(6):394-400. PubMed ID: 15973073
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of bcl-2, bax, P53 in neuroendocrine carcinomas of the lung].
Shao Y; Zhao P; Li X
Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):55-9. PubMed ID: 21144283
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
[TBL] [Abstract][Full Text] [Related]
19. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
20. Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Korobowicz E; Korszen-Pilecka I; Zdunek M
Lung Cancer; 2006 Jan; 51(1):61-9. PubMed ID: 16297499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
